+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Allergy Shots Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
Allergy Shots Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
New

Allergy Shots Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 210 Pages
  • July 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 5918293
Description Jump to:
The global allergy shots market is poised for substantial growth over the coming years, driven by increasing prevalence of allergic conditions and the growing need for long-term, effective treatment solutions. According to market projections, the global allergy shots market is expected to grow from US$ 3.1 billion in 2025 to US$ 6.1 billion by 2032, expanding at a robust CAGR of 10.15% during the forecast period.

Market Insights

Allergy shots, also known as allergen immunotherapy, offer long-term relief by desensitizing the immune system to specific allergens such as pollen, dust mites, pet dander, insect venom, and mold. Unlike symptomatic treatments, these injections target the root cause of allergic reactions, offering a more permanent solution for many patients. They function similarly to vaccines by gradually building the immune system’s tolerance to allergens through regular and increasing doses.

This form of treatment is increasingly favored among patients suffering from persistent and severe allergic rhinitis, asthma, and insect venom hypersensitivity. Allergy shots are shown to reduce the need for long-term medication, provide symptom relief even after discontinuation, and prevent the progression of allergic diseases.

Market Drivers

A significant driver for the allergy shots market is the rising incidence of various allergy types globally. Environmental changes, increasing air pollution, urbanization, and shifts in dietary patterns have all contributed to a growing number of allergy cases. According to various global health estimates, allergic rhinitis affects up to 30% of the population in certain regions.

Additionally, continuous innovation in allergen-specific immunotherapies, including recombinant and synthetic formulations, is enhancing the effectiveness of allergy shots. Biotechnology companies are developing faster-acting and more precise solutions to improve patient adherence and outcomes. Increasing awareness about allergy prevention and long-term treatment benefits also plays a key role in shaping market trends.

Business Opportunity

The allergy shots market presents lucrative opportunities for companies investing in research and product development. Strategic mergers, collaborations, and acquisitions are commonly adopted by key market players to expand their therapeutic portfolios and geographic presence.

For instance, partnerships like the one between Aimmune Therapeutics and Allergy Partners aim to increase access to specialized food allergy treatments through national networks. Similarly, Anergis’ collaboration with Virometix to explore synthetic virus-like particles highlights the sector’s push toward next-generation immunotherapies.

Regional Analysis

The United States continues to dominate the North American allergy shots market due to increased investment in healthcare R&D, rising allergy prevalence, and supportive government funding. The region benefits from a well-established network of allergists and immunologists offering specialized treatment services.

Germany leads the European market with a strong focus on product innovation and accessibility. For example, the launch of ITULAZAX, a convenient once-daily sublingual tablet for tree pollen allergies, has strengthened Germany’s market position.

In Asia, Japan is emerging as a key market owing to the high prevalence of seasonal allergies, particularly those linked to cedar pollen. The regional market benefits from ongoing epidemiological studies and efforts to enhance treatment protocols for widespread allergic conditions.

Key Players

The global allergy shots market is consolidated with a few major players leading through innovation and expansion strategies. Notable companies include:

  • ALK Abello
  • Stallergenes Greer
  • Allergy Therapeutics
  • Aimmune Therapeutics
  • Anergis
  • Arrayit Corporation
  • Biomay AG
  • HAL Allergy Group
  • DBV Technologies
These players are actively involved in clinical trials, product development, and regional collaborations aimed at improving patient accessibility and therapeutic efficiency.

Segmentation

By Product:

  • Injections
  • Sublingual Immunotherapy (SLIT)

By Immunotherapy Type:

  • Subcutaneous Immunotherapy (SCIT)
  • Sublingual Immunotherapy (SLIT)

By Indication:

  • Allergic Rhinitis
  • Allergic Asthma
  • Venom Allergy
  • Food Allergy
  • Others

By Allergen Type:

  • Pollen
  • Dust Mites
  • Pet Dander
  • Mold
  • Insect Venom
  • Others

By Distribution Channel:

  • Institutional Sales (Government Hospitals, Semi-Government Hospitals, Private Hospitals)
  • Retail Sales (Pharmacies, Online Pharmacies)

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Latin America
  • Middle East & Africa

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Allergy Shots Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Production Output and Trade Statistics, 2019-2023
3.1. Global Allergy Shots Market Production Output, by Region, Value (US$ Bn) and Volume (‘000 Units), 2019-2023
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa
4. Price Analysis, 2019-2023
4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2019-2023
4.2. Prominent Factor Affecting Allergy Shots Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit
5. Global Allergy Shots Market Outlook, 2019-2032
5.1. Global Allergy Shots Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019-2032
5.1.1. Key Highlights
5.1.1.1. SLIT Tablets
5.1.1.1.1. Odactra
5.1.1.1.2. Grastek
5.1.1.1.3. Ragwitek
5.1.1.1.4. Oralair
5.1.1.1.5. Actair
5.1.1.1.6. Others
5.1.1.2. Oral
5.1.1.2.1. Palforzia
5.1.1.2.2. Others
5.1.1.3. Injections
5.1.1.4. Others
5.2. Global Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Sublingual Immunotherapy (SLIT)
5.2.1.2. Subcutaneous Immunotherapy (SCIT)
5.2.1.2.1. Specific Immunotherapy
5.2.1.3. Others
5.3. Global Allergy Shots Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Allergic Rhinitis
5.3.1.2. Allergic Asthma
5.3.1.3. Food Allergy
5.3.1.4. Atopic Dermatitis
5.3.1.5. Others
5.4. Global Allergy Shots Market Outlook, by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Pollens
5.4.1.1.1. Grass Pollens
5.4.1.1.2. Weed Pollens
5.4.1.1.3. Tree Pollens
5.4.1.2. House Dust Mites (HDM)
5.4.1.3. Mold
5.4.1.4. Animal Dander
5.4.1.5. Bee Venom
5.4.1.6. Cockroaches/Insects
5.4.1.7. Others
5.5. Others Global Allergy Shots Market Outlook, by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
5.5.1. Key Highlights
5.5.1.1. Institutional Sales
5.5.1.1.1. Government Hospitals
5.5.1.1.2. Semi-Government Hospitals
5.5.1.1.3. Private Hospitals
5.5.1.2. Retail Sales
5.5.1.2.1. Retail Pharmacy
5.5.1.2.2. Drug Stores
5.5.1.2.3. Online Pharmacy
5.6. Global Allergy Shots Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2019-2032
5.6.1. Key Highlights
5.6.1.1. North America
5.6.1.2. Europe
5.6.1.3. Asia Pacific
5.6.1.4. Latin America
5.6.1.5. Middle East & Africa
6. North America Allergy Shots Market Outlook, 2019-2032
6.1. North America Allergy Shots Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019-2032
6.1.1. Key Highlights
6.1.1.1. SLIT Tablets
6.1.1.1.1. Odactra
6.1.1.1.2. Grastek
6.1.1.1.3. Ragwitek
6.1.1.1.4. Oralair
6.1.1.1.5. Actair
6.1.1.1.6. Others
6.1.1.2. Oral
6.1.1.2.1. Palforzia
6.1.1.2.2. Others
6.1.1.3. Injections
6.1.1.4. Others
6.2. North America Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Sublingual Immunotherapy (SLIT)
6.2.1.2. Subcutaneous Immunotherapy (SCIT)
6.2.1.2.1. Specific Immunotherapy
6.2.1.3. Others
6.3. North America Allergy Shots Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Allergic Rhinitis
6.3.1.2. Allergic Asthma
6.3.1.3. Food Allergy
6.3.1.4. Atopic Dermatitis
6.3.1.5. Others
6.4. North America Allergy Shots Market Outlook, by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
6.4.1. Key Highlights
6.4.1.1. Pollens
6.4.1.1.1. Grass Pollens
6.4.1.1.2. Weed Pollens
6.4.1.1.3. Tree Pollens
6.4.1.2. House Dust Mites (HDM)
6.4.1.3. Mold
6.4.1.4. Animal Dander
6.4.1.5. Bee Venom
6.4.1.6. Cockroaches/Insects
6.4.1.7. Others
6.5. North America Allergy Shots Market Outlook, by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
6.5.1. Key Highlights
6.5.1.1. Institutional Sales
6.5.1.1.1. Government Hospitals
6.5.1.1.2. Semi-Government Hospitals
6.5.1.1.3. Private Hospitals
6.5.1.2. Retail Sales
6.5.1.2.1. Retail Pharmacy
6.5.1.2.2. Drug Stores
6.5.1.2.3. Online Pharmacy
6.5.2. BPS Analysis/Market Attractiveness Analysis
6.6. North America Allergy Shots Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019-2032
6.6.1. Key Highlights
6.6.1.1. U.S. Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
6.6.1.2. U.S. Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
6.6.1.3. U.S. Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
6.6.1.4. U.S. Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
6.6.1.5. U.S. Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
6.6.1.6. Canada Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
6.6.1.7. Canada Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
6.6.1.8. Canada Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
6.6.1.9. Canada Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
6.6.1.10. Canada Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
6.6.2. BPS Analysis/Market Attractiveness Analysis
7. Europe Allergy Shots Market Outlook, 2019-2032
7.1. Europe Allergy Shots Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019-2032
7.1.1. Key Highlights
7.1.1.1. SLIT Tablets
7.1.1.1.1. Odactra
7.1.1.1.2. Grastek
7.1.1.1.3. Ragwitek
7.1.1.1.4. Oralair
7.1.1.1.5. Actair
7.1.1.1.6. Others
7.1.1.2. Oral
7.1.1.2.1. Palforzia
7.1.1.2.2. Others
7.1.1.3. Injections
7.1.1.4. Others
7.2. Europe Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
7.2.1. Key Highlights
7.2.1.1. Sublingual Immunotherapy (SLIT)
7.2.1.2. Subcutaneous Immunotherapy (SCIT)
7.2.1.2.1. Specific Immunotherapy
7.2.1.3. Others
7.3. Europe Allergy Shots Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Allergic Rhinitis
7.3.1.2. Allergic Asthma
7.3.1.3. Food Allergy
7.3.1.4. Atopic Dermatitis
7.3.1.5. Others
7.4. Europe Allergy Shots Market Outlook, by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Pollens
7.4.1.1.1. Grass Pollens
7.4.1.1.2. Weed Pollens
7.4.1.1.3. Tree Pollens
7.4.1.2. House Dust Mites (HDM)
7.4.1.3. Mold
7.4.1.4. Animal Dander
7.4.1.5. Bee Venom
7.4.1.6. Cockroaches/Insects
7.4.1.7. Others
7.5. Europe Allergy Shots Market Outlook, by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
7.5.1. Key Highlights
7.5.1.1. Institutional Sales
7.5.1.1.1. Government Hospitals
7.5.1.1.2. Semi-Government Hospitals
7.5.1.1.3. Private Hospitals
7.5.1.2. Retail Sales
7.5.1.2.1. Retail Pharmacy
7.5.1.2.2. Drug Stores
7.5.1.2.3. Online Pharmacy
7.5.2. BPS Analysis/Market Attractiveness Analysis
7.6. Europe Allergy Shots Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1. Key Highlights
7.6.1.1. Germany Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.2. Germany Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.3. Germany Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.4. Germany Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.5. Germany Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.6. U.K. Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.7. U.K. Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.8. U.K. Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.9. U.K. Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.10. U.K. Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.11. France Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.12. France Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.13. France Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.14. France Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.15. France Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.16. Italy Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.17. Italy Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.18. Italy Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.19. Italy Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.20. Italy Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.21. Turkey Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.22. Turkey Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.23. Turkey Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.24. Turkey Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.25. Turkey Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.26. Russia Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.27. Russia Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.28. Russia Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.29. Russia Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.30. Russia Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.31. Rest of Europe Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.32. Rest of Europe Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.33. Rest of Europe Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.34. Rest of Europe Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.1.35. Rest of Europe Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
7.6.2. BPS Analysis/Market Attractiveness Analysis
8. Asia Pacific Allergy Shots Market Outlook, 2019-2032
8.1. Asia Pacific Allergy Shots Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019-2032
8.1.1. Key Highlights
8.1.1.1. SLIT Tablets
8.1.1.1.1. Odactra
8.1.1.1.2. Grastek
8.1.1.1.3. Ragwitek
8.1.1.1.4. Oralair
8.1.1.1.5. Actair
8.1.1.1.6. Others
8.1.1.2. Oral
8.1.1.2.1. Palforzia
8.1.1.2.2. Others
8.1.1.3. Injections
8.1.1.4. Others
8.2. Asia Pacific Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Sublingual Immunotherapy (SLIT)
8.2.1.2. Subcutaneous Immunotherapy (SCIT)
8.2.1.2.1. Specific Immunotherapy
8.2.1.3. Others
8.3. Asia Pacific Allergy Shots Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Allergic Rhinitis
8.3.1.2. Allergic Asthma
8.3.1.3. Food Allergy
8.3.1.4. Atopic Dermatitis
8.3.1.5. Others
8.4. Asia Pacific Allergy Shots Market Outlook, by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
8.4.1. Key Highlights
8.4.1.1. Pollens
8.4.1.1.1. Grass Pollens
8.4.1.1.2. Weed Pollens
8.4.1.1.3. Tree Pollens
8.4.1.2. House Dust Mites (HDM)
8.4.1.3. Mold
8.4.1.4. Animal Dander
8.4.1.5. Bee Venom
8.4.1.6. Cockroaches/Insects
8.4.1.7. Others
8.5. Asia Pacific Allergy Shots Market Outlook, by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
8.5.1. Key Highlights
8.5.1.1. Institutional Sales
8.5.1.1.1. Government Hospitals
8.5.1.1.2. Semi-Government Hospitals
8.5.1.1.3. Private Hospitals
8.5.1.2. Retail Sales
8.5.1.2.1. Retail Pharmacy
8.5.1.2.2. Drug Stores
8.5.1.2.3. Online Pharmacy
8.5.2. BPS Analysis/Market Attractiveness Analysis
8.6. Asia Pacific Allergy Shots Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1. Key Highlights
8.6.1.1. China Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.2. China Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.3. China Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.4. China Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.5. China Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.6. Japan Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.7. Japan Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.8. Japan Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.9. Japan Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.10. Japan Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.11. South Korea Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.12. South Korea Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.13. South Korea Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.14. South Korea Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.15. South Korea Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.16. India Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.17. India Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.18. India Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.19. India Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.20. India Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.21. Southeast Asia Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.22. Southeast Asia Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.23. Southeast Asia Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.24. Southeast Asia Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.25. Southeast Asia Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.26. Rest of Asia Pacific Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.27. Rest of Asia Pacific Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.28. Rest of Asia Pacific Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.29. Rest of Asia Pacific Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.1.30. Rest of Asia Pacific Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
8.6.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Allergy Shots Market Outlook, 2019-2032
9.1. Latin America Allergy Shots Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019-2032
9.1.1. Key Highlights
9.1.1.1. SLIT Tablets
9.1.1.1.1. Odactra
9.1.1.1.2. Grastek
9.1.1.1.3. Ragwitek
9.1.1.1.4. Oralair
9.1.1.1.5. Actair
9.1.1.1.6. Others
9.1.1.2. Oral
9.1.1.2.1. Palforzia
9.1.1.2.2. Others
9.1.1.3. Injections
9.1.1.4. Others
9.2. Latin America Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
9.2.1.1. Sublingual Immunotherapy (SLIT)
9.2.1.2. Subcutaneous Immunotherapy (SCIT)
9.2.1.2.1. Specific Immunotherapy
9.2.1.3. Others
9.3. Latin America Allergy Shots Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
9.3.1. Key Highlights
9.3.1.1. Allergic Rhinitis
9.3.1.2. Allergic Asthma
9.3.1.3. Food Allergy
9.3.1.4. Atopic Dermatitis
9.3.1.5. Others
9.4. Latin America Allergy Shots Market Outlook, by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
9.4.1. Key Highlights
9.4.1.1. Pollens
9.4.1.1.1. Grass Pollens
9.4.1.1.2. Weed Pollens
9.4.1.1.3. Tree Pollens
9.4.1.2. House Dust Mites (HDM)
9.4.1.3. Mold
9.4.1.4. Animal Dander
9.4.1.5. Bee Venom
9.4.1.6. Cockroaches/Insects
9.4.1.7. Others
9.5. Latin America Allergy Shots Market Outlook, by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
9.5.1. Key Highlights
9.5.1.1. Institutional Sales
9.5.1.1.1. Government Hospitals
9.5.1.1.2. Semi-Government Hospitals
9.5.1.1.3. Private Hospitals
9.5.1.2. Retail Sales
9.5.1.2.1. Retail Pharmacy
9.5.1.2.2. Drug Stores
9.5.1.2.3. Online Pharmacy
9.5.2. BPS Analysis/Market Attractiveness Analysis
9.6. Latin America Allergy Shots Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019-2032
9.6.1. Key Highlights
9.6.1.1. Brazil Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
9.6.1.2. Brazil Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
9.6.1.3. Brazil Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
9.6.1.4. Brazil Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
9.6.1.5. Brazil Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
9.6.1.6. Mexico Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
9.6.1.7. Mexico Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
9.6.1.8. Mexico Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
9.6.1.9. Mexico Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
9.6.1.10. Mexico Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
9.6.1.11. Argentina Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
9.6.1.12. Argentina Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
9.6.1.13. Argentina Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
9.6.1.14. Argentina Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
9.6.1.15. Argentina Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
9.6.1.16. Rest of Latin America Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
9.6.1.17. Rest of Latin America Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
9.6.1.18. Rest of Latin America Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
9.6.1.19. Rest of Latin America Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
9.6.1.20. Rest of Latin America Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
9.6.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Allergy Shots Market Outlook, 2019-2032
10.1. Middle East & Africa Allergy Shots Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019-2032
10.1.1. Key Highlights
10.1.1.1. SLIT Tablets
10.1.1.1.1. Odactra
10.1.1.1.2. Grastek
10.1.1.1.3. Ragwitek
10.1.1.1.4. Oralair
10.1.1.1.5. Actair
10.1.1.1.6. Others
10.1.1.2. Oral
10.1.1.2.1. Palforzia
10.1.1.2.2. Others
10.1.1.3. Injections
10.1.1.4. Others
10.2. Middle East & Africa Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
10.2.1. Key Highlights
10.2.1.1. Sublingual Immunotherapy (SLIT)
10.2.1.2. Subcutaneous Immunotherapy (SCIT)
10.2.1.2.1. Specific Immunotherapy
10.2.1.3. Others
10.3. Middle East & Africa Allergy Shots Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
10.3.1. Key Highlights
10.3.1.1. Allergic Rhinitis
10.3.1.2. Allergic Asthma
10.3.1.3. Food Allergy
10.3.1.4. Atopic Dermatitis
10.3.1.5. Others
10.4. Middle East & Africa Allergy Shots Market Outlook, by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
10.4.1. Key Highlights
10.4.1.1. Cell Wall Synthesis Inhibitors
10.4.1.2. Protein Synthesis Inhibitors
10.4.1.3. DNA Synthesis Inhibitors
10.4.1.4. RNA Synthesis Inhibitors
10.4.1.5. Others
10.5. Middle East & Africa Allergy Shots Market Outlook, by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
10.5.1. Key Highlights
10.5.1.1. Institutional Sales
10.5.1.1.1. Government Hospitals
10.5.1.1.2. Semi-Government Hospitals
10.5.1.1.3. Private Hospitals
10.5.1.2. Retail Sales
10.5.1.2.1. Retail Pharmacy
10.5.1.2.2. Drug Stores
10.5.1.2.3. Online Pharmacy
10.5.2. BPS Analysis/Market Attractiveness Analysis
10.6. Middle East & Africa Allergy Shots Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1. Key Highlights
10.6.1.1. GCC Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.2. GCC Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.3. GCC Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.4. GCC Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.5. GCC Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.6. South Africa Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.7. South Africa Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.8. South Africa Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.9. South Africa Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.10. South Africa Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.11. Egypt Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.12. Egypt Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.13. Egypt Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.14. Egypt Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.15. Egypt Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.16. Nigeria Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.17. Nigeria Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.18. Nigeria Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.19. Nigeria Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.20. Nigeria Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.21. Rest of Middle East & Africa Allergy Shots Market by Product, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.22. Rest of Middle East & Africa Allergy Shots Market by Immunotherapy, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.23. Rest of Middle East & Africa Allergy Shots Market by Indication, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.24. Rest of Middle East & Africa Allergy Shots Market by Allergen, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.1.25. Rest of Middle East & Africa Allergy Shots Market by Distribution channel, Value (US$ Bn) and Volume (Units), 2019-2032
10.6.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. By Species vs by Immunotherapy Heat map
11.2. Manufacturer vs by Immunotherapy Heat map
11.3. Company Market Share Analysis, 2025
11.4. Competitive Dashboard
11.5. Company Profiles
11.5.1. Stallergenes Greer
11.5.1.1. Company Overview
11.5.1.2. Product Portfolio
11.5.1.3. Financial Overview
11.5.1.4. Business Strategies and Development
11.5.2. Allergy Therapeutics
11.5.2.1. Company Overview
11.5.2.2. Product Portfolio
11.5.2.3. Financial Overview
11.5.2.4. Business Strategies and Development
11.5.3. Aimmune Therapeutics
11.5.3.1. Company Overview
11.5.3.2. Product Portfolio
11.5.3.3. Financial Overview
11.5.3.4. Business Strategies and Development
11.5.4. Anergis
11.5.4.1. Company Overview
11.5.4.2. Product Portfolio
11.5.4.3. Financial Overview
11.5.4.4. Business Strategies and Development
11.5.5. Arrayit Corporation
11.5.5.1. Company Overview
11.5.5.2. Product Portfolio
11.5.5.3. Financial Overview
11.5.5.4. Business Strategies and Development
11.5.6. Biomay AG
11.5.6.1. Company Overview
11.5.6.2. Product Portfolio
11.5.6.3. Financial Overview
11.5.6.4. Business Strategies and Development
11.5.7. HAL Allergy Group
11.5.7.1. Company Overview
11.5.7.2. Product Portfolio
11.5.7.3. Financial Overview
11.5.7.4. Business Strategies and Development
11.5.8. DBV Technologies
11.5.8.1. Company Overview
11.5.8.2. Product Portfolio
11.5.8.3. Financial Overview
11.5.8.4. Business Strategies and Development
12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations

Companies Mentioned

  • ALK Abello
  • Stallergenes Greer
  • Allergy Therapeutics
  • Aimmune Therapeutics
  • Anergis
  • Arrayit Corporation
  • Biomay AG
  • HAL Allergy Group
  • DBV Technologies

Related Topics

Related Reports

Allergy Shots - Global Strategic Business Report - Product Image

Allergy Shots - Global Strategic Business Report

  • Report
  • 584 Pages
  • Global
From
Nasal Allergy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Nasal Allergy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 260 Pages
  • Global
From
Allergy Immunotherapy Market Report and Forecast 2024-2032 - Product Image

Allergy Immunotherapy Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Allergy Treatment Market Report 2025 - Product Image

Allergy Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Pollen Allergy Market Report 2025 - Product Image

Pollen Allergy Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.